Literature DB >> 23416514

Povidone-iodine contact time and lid speculum use during intravitreal injection.

Duncan A Friedman1, John O Mason, Tracy Emond, Gerald McGwin.   

Abstract

PURPOSE: To determine the time necessary for 5% povidone-iodine (PI) to cause a significant reduction in colony-forming units and whether a lid speculum increases the conjunctival flora.
METHODS: This was a prospective randomized study of 131 eyes undergoing intravitreal injection. Conjunctival samples were collected in a prospective protocol at three points before intravitreal injection: (1) no intervention (baseline), (2) after placement of a lid speculum, and (3) after treatment with 5% PI. Participants were randomized into three different PI exposure intervals. Cultures were incubated for 6 days, and the resulting colony-forming units were tallied for each intervention.
RESULTS: Use of 5% PI caused significant decrease in the number of colony-forming units (P < 0.0001). Exposure to PI for 15 seconds did not cause a significant reduction in conjunctival bacteria (P = 0.08), but a significant reduction was observed after 30 seconds of exposure and beyond (P = 0.0003). Placement of a lid speculum did not result in a significant increase or decrease in the number of colony-forming units when compared with baseline (P = 0.47).
CONCLUSION: The use of 5% PI causes a significant reduction in bacterial colonies, and 30 seconds of exposure appears to be an adequate time to decrease conjunctival bacterial counts. Lid speculum use before intravitreal injection does not affect the overall conjunctival flora.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416514     DOI: 10.1097/IAE.0b013e3182877585

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  19 in total

1.  Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength.

Authors:  Maxwell S Stem; Prethy Rao; Ivan J Lee; Maria A Woodward; Lisa J Faia; Jeremy D Wolfe; Antonio Capone; Douglas Covert; A Bawa Dass; Kimberly A Drenser; Bruce R Garretson; Tarek S Hassan; Alan Margherio; Kean T Oh; Paul V Raephaelian; Sandeep Randhawa; Scott Sneed; Michael T Trese; Sunita Yedavally; George A Williams; Alan J Ruby
Journal:  Ophthalmol Retina       Date:  2018-09-25

Review 2.  Prevention and treatment of injection-related endophthalmitis.

Authors:  Charles Q Yu; Christopher N Ta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-08       Impact factor: 3.117

3.  Culture-Proven Endophthalmitis After Intravitreal Injection: A 10-Year Analysis.

Authors:  Joseph M Simonett; Austin Igelman; Stanford C Taylor; J Peter Campbell; Thomas S Hwang; Phoebe Lin; Andreas K Lauer; Christina J Flaxel
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-01-01       Impact factor: 1.300

4.  Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.

Authors:  Jeff H Pettey; Mark D Mifflin; Randall J Olson
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-19       Impact factor: 2.671

Review 5.  Endophthalmitis: state of the art.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Krishna Kishor; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-01-08

Review 6.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

7.  Anterior infectious necrotizing scleritis secondary to Pseudomonas aeruginosa infection following intravitreal ranibizumab injection.

Authors:  Razek Georges Coussa; Susan M Wakil; Hady Saheb; David E Lederer; Karin M Oliver; Devinder P Cheema
Journal:  Am J Ophthalmol Case Rep       Date:  2016-10-29

8.  Role of intracameral antibiotics in endophthalmitis prophylaxis following-cataract surgery.

Authors:  Jeewan S Titiyal; Manpreet Kaur
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

9.  Intravitreal Injection of Bevacizumab: Review of our previous Experience.

Authors:  Mehrdad Afarid; Ali Sadegi Sarvestani; Feisal Rahat; Ali Azimi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 10.  Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections.

Authors:  P Et Lau; K S Jenkins; C J Layton
Journal:  J Ophthalmol       Date:  2018-07-24       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.